During the past decade, Cancer Hospital Chinese Academy of Medical Sciences conducted 319 clinical trials. In the 10-year time frame, 319 clinical trials started and 23 clinical trials were completed, i.e. on average, 7.2% percent of trials that started reached the finish line to date. In the past 5 years, 187 clinical trials started and 12 clinical trials were completed. i.e. 6.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences" #1 sponsor was "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 67 trials, followed by "Jiangsu HengRui Medicine Co., Ltd." with 20 trials sponsored, "BeiGene" with 16 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 15 trials sponsored and "Hoffmann-La Roche" with 15 trials sponsored. Other sponsors include 245 different institutions and companies that sponsored additional 150 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Hospital Chinese Academy of Medical Sciences" #1 collaborator was "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 17 trials as a collaborator, "Peking University Cancer Hospital & Institute" with 9 trials as a collaborator, "Hebei Medical University Fourth Hospital" with 8 trials as a collaborator, "Beijing Hospital" with 7 trials as a collaborator and "Henan Cancer Hospital" with 7 trials as a collaborator. Other collaborators include 236 different institutions and companies that were collaborators in the rest 167 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Hospital Chinese Academy of Medical Sciences" are "Breast Cancer" (29 trials), "Non-small Cell Lung Cancer" (16 trials), "Advanced Solid Tumor" (11 trials), "Colorectal Cancer" (10 trials) and "Ovarian Cancer" (9 trials). Many other conditions were trialed in "Cancer Hospital Chinese Academy of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Cancer Hospital Chinese Academy of Medical Sciences" are "Drug" (318 trials), "Biological" (29 trials), "Radiation" (21 trials), "Device" (17 trials) and "Other" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Cisplatin" (22 trials), "Carboplatin" (18 trials), "Paclitaxel" (17 trials) and "Tislelizumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Hospital Chinese Academy of Medical Sciences" are 320 trials for "All" genders, 56 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 175 active trials in "Cancer Hospital Chinese Academy of Medical Sciences". 21 are not yet recruiting, 105 are recruiting, 47 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 89 completed trials in Cancer Hospital Chinese Academy of Medical Sciences, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Hospital Chinese Academy of Medical Sciences, 95 "Phase 1" clinical trials were conducted, 140 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 21 trials that are defined as “Not Applicable".